Colchicine for CPPD: reducing pain and inflammation
Treatments studied
Part of Bones, joints & muscles clinical trials.
This trial tests if colchicine can reduce pain and swelling in people with CPPD (calcium pyrophosphate deposition disease), a type of arthritis. If you have had a swollen, red, or warm joint in the last 3 months and your pain is moderate or higher, this study may offer a possible treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have CPPD (a type of arthritis caused by calcium crystals in the joints).
- You have had at least one joint that is swollen, red, or warm to the touch in the past 3 months.
- Your pain level at screening is at least 30 on a 0-100 scale (0 = no pain, 100 = worst pain).
- You are 40 years or older.
- You are not currently taking colchicine, or you are willing to stop taking it for 30 days before starting the study.
- You do not have gout, rheumatoid arthritis, psoriatic arthritis, or cirrhosis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking colchicine around the time of surgery can reduce bad events after surgery in people at higher heart risk. It focuses on helping prevent complications related to inflammation after an operation.
This study looks at calcium pyrophosphate deposition (CPPD) disease, which causes joint inflammation. It aims to understand the disease better by studying people with either an acute first episode or ongoing chronic CPPD arthritis.
This trial tests if tocilizumab can help people with chronic pain from CPPD crystal arthritis (also called pseudogout). It is for people whose pain has not responded to usual treatments like colchicine, NSAIDs, or steroids.
This trial tests whether colchicine, a drug that reduces inflammation, can help prevent further heart problems or strokes in people with moderate chronic kidney disease. You may be eligible if you have kidney disease and have had a heart attack, stroke, or related event in the past.
This trial tests if a low dose of colchicine, a medicine that reduces inflammation, can help improve blood vessel and bone health in people with moderate chronic kidney disease.
This trial tests if the anti-inflammatory drug colchicine can help people with non-severe coronary artery plaque seen on a CT scan. It may be an option if you have stable chest pain or related symptoms and your heart arteries are partly blocked but not severely.
Hear when a new CPPD - Calcium Pyrophosphate Deposition Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.